APA (7th ed.) Citation

Benes̆ová, M., Afshar-Oromieh, A., Kratochwil, C., Mier, W., & Haberkorn, U. (2015). Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer. Journal of nuclear medicine, 56(6), . https://doi.org/10.2967/jnumed.114.147413

Chicago Style (17th ed.) Citation

Benes̆ová, Martina, Ali Afshar-Oromieh, Clemens Kratochwil, Walter Mier, and Uwe Haberkorn. "Preclinical Evaluation of a Tailor-made DOTA-conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer." Journal of Nuclear Medicine 56, no. 6 (2015). https://doi.org/10.2967/jnumed.114.147413.

MLA (9th ed.) Citation

Benes̆ová, Martina, et al. "Preclinical Evaluation of a Tailor-made DOTA-conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer." Journal of Nuclear Medicine, vol. 56, no. 6, 2015, https://doi.org/10.2967/jnumed.114.147413.